IP Library › Assignment 038502/0813
Patent Assignment
Reel/Frame 038502/0813

Change of Name

Recorded: 2016-04-22 Pages: 3
Assignor
LIGHTLAKE THERAPEUTICS, INC.
Executed: 2016-01-28
Assignee
OPIANT PHARMACEUTICALS, INC.
401 WILSHIRE BLVD., 12TH FLOOR, SANTA MONICA, CALIFORNIA, 90401
Covered Properties (3)
Nasal Drug Products and Methods of Their Use
Patent: 9,211,253 →
Application: 14/659,472 →
Publication: US 2015/0258019
Nasal Drug Products and Methods of Their Use
Patent: 9,480,644 →
Application: 14/942,344 →
Publication: US 2016/0166503
Nasal Drug Products and Methods of Their Use
Patent: 9,468,747 →
Application: 14/950,707 →
Publication: US 2016/0184294
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 3, 2015
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: LIGHTLAKE THERAPEUTICS, INC.
Reel/Frame 035328/0599 →
Assignment of Assignor's Interest Apr 22, 2016
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: LIGHTLAKE THERAPEUTICS, INC.
Reel/Frame 038357/0246 →
Assignment of Assignor's Interest Jan 26, 2017
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 041097/0286 →
Assignment of Assignor's Interest Jun 14, 2023
From: OPIANT PHARMACEUTICALS, INC.
To: INDIVIOR UK LIMITED
Reel/Frame 063944/0323 →